HAVRON ABRAHAM 4
4 · PROLOR Biotech, Inc. · Filed Jan 4, 2011
Insider Transaction Report
Form 4
HAVRON ABRAHAM
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2010-12-31+200,000→ 200,000 totalExercise: $6.47Exp: 2020-12-31→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Option vests in four equal annual installments commencing on December 31, 2011.
- [F2]Granted pursuant to the Modigene Inc. 2007 Equity Incentive Plan.